Gastrointestinal bleeding (GIB) represents a potentially life-threatening condition and is the main indication for gastrointestinal endoscopy. Its incidence is given with roughly 150 patients per 100000 population and year, with a mortality rate of still 10% ].
Various bleeding sources may be identified and they may be induced either because of an underlying morbidity with ulcerative and nonulcerative lesions, respectively (e.g., ulcers, esophageal varices, and gastrointestinal vascular malformations), and malignancy or as a consequence of iatrogenic interventions (e.g., postpolypectomy bleeding) In addition, GIB becomes an emerging issue in the light of increasing numbers of disease entities requiring strict anticoagulant therapy with increasing use of new direct oral anticoagulants (DOAC) ]. Hemostasis can be achieved according to the type of lesion and extent of bleeding by injection…
